Magdalena Cerdá

Magdalena Cerdá

Auto-generated profile, based on publicly available information

Magdalena Cerdá

Center for Opioid Epidemiology and Policy, Department of Population Health New York University School of Medicine New York NY USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
MCMagdalena Cerdá
Magdalena Cerdá
CMChristine Mauro
Christine Mauro
AHAva Hamilton
Ava Hamilton
NLNatalie S. Levy
Natalie S. Levy
JSJulián Santaella-Tenorio
Julián Santaella-Tenorio
SMSilvia S. Martins
Silvia S. Martins
Marijuana is one of the world’s most widely used psychoactive substances. Approximately 183 million people, or 3.8% of the world’s population, used marijuana in 2015.1 Although occasional marijuana use is not associated with substantial problems, long-term, heavy use is linked to psychological and physical health concerns,2-4 lower educational attainment,5 decline in social class, unemployment,6,7 and motor vehicle crashes.8,9

1 January 2012 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MCMagdalena Cerdá
Magdalena Cerdá
MWMelanie Wall
Melanie Wall
KKKatherine M. Keyes
Katherine M. Keyes
SGSandro Galea
Sandro Galea
DHDeborah Hasin
Deborah Hasin

1 April 2018 in Annual Review of Public Health
Verified
Journal Article
Open access
MTMelissa Tracy
Melissa Tracy
MCMagdalena Cerdá
Magdalena Cerdá
KKKatherine M. Keyes
Katherine M. Keyes
Agent-based modeling is a computational approach in which agents with a specified set of characteristics interact with each other and with their environment according to predefined rules. We review key areas in public health where agent-based modeling has been adopted, including both communicable and noncommunicable disease, health behaviors, and social epidemiology. Wealso describe the main strengths and limitations of this approach for questions with public health relevance. Finally, we describe both methodologic and substantive future directions that we believe will enhance the value of agent-based modeling for public health. In particular, advances in model validation, comparisons with other causal modeling procedures, and the expansion of the models to consider comorbidity and joint influences more systematically will improve the utility of this approach to inform public health research, practice, and policy. Expected final online publication date for the Annual Review of Public Health Volume 39 is A...

1 February 2017 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
MCMagdalena Cerdá
Magdalena Cerdá
MWMelanie Wall
Melanie Wall
TFTianshu Feng
Tianshu Feng
KKKatherine M. Keyes
Katherine M. Keyes
ASAaron Sarvet
Aaron Sarvet
DHDeborah S. Hasin
Deborah S. Hasin
Historical shifts are occurring in attitudes toward marijuana and in state marijuana policy in the United States. The proportion of adolescents who perceive great risk of harm in using marijuana once or twice a week has decreased from 55% in 2007 to 44% in 2012,1 and 58% of adults now support legalization of recreational marijuana.2 Quiz Ref ID Since 1996, 28 states and Washington, DC, have passed legislation permitting the use of marijuana for medical purposes.3 Quiz Ref ID In 2012, Colorado and Washington became the first 2 states to legalize the recreational use of marijuana for adults. Alaska, Oregon, and Washington, DC, followed suit in 2014, and California, Maine, Massachusetts, and Nevada approved the legalization of recreational adult use in the November 2016 ballots.4 The potential effect of legalization for recreational use on rates of marijuana use in the United States is a topic of considerable debate.5-9

1 April 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
WGWilliam C. Goedel
William C. Goedel
ASAaron Shapiro
Aaron Shapiro
MCMagdalena Cerdá
Magdalena Cerdá
JTJennifer W. Tsai
Jennifer W. Tsai
SHScott E. Hadland
Scott E. Hadland
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
Since 1999, more than 700 000 people in the US have died of drug overdose, including more than 350 000 people who have died of opioid-involved overdose.1-3 Based on current trends, it is projected that 700 000 more individuals will die of opioid-involved overdose in the next decade.4 The current criterion standard for treatment of opioid use disorder (OUD), as approved by the Food and Drug Administration, includes methadone, buprenorphine, and naltrexone.5 In a 2018 retrospective cohort study in Massachusetts,6 all-cause and opioid-related mortality rates were decreased by half among adults who received methadone or buprenorphine within 1 year after a nonfatal opioid-involved overdose, underscoring the strong protective benefits of these medications. However, few individuals at risk for opioid-related harms receive these medications in a timely fashion.7

1 September 2015 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MCMagdalena Cerdá
Magdalena Cerdá
JSJulián Santaella
Julián Santaella
BMBrandon D.L. Marshall
Brandon D.L. Marshall
JKJune H. Kim
June H. Kim
SMSilvia S. Martins
Silvia S. Martins